Calcimedica, Common Stock Stock Alpha and Beta Analysis
| CALC Stock | 2.78 0.03 1.07% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as CalciMedica, Common Stock. It also helps investors analyze the systematic and unsystematic risks associated with investing in CalciMedica, Common over a specified time horizon. Remember, high CalciMedica, Common's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to CalciMedica, Common's market risk premium analysis include:
Beta 1.2 | Alpha (0.50) | Risk 5.77 | Sharpe Ratio (0.08) | Expected Return (0.47) |
Enterprise Value |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
CalciMedica, |
CalciMedica, Common Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. CalciMedica, Common market risk premium is the additional return an investor will receive from holding CalciMedica, Common long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in CalciMedica, Common. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate CalciMedica, Common's performance over market.| α | -0.5 | β | 1.20 |
CalciMedica, Common expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of CalciMedica, Common's Buy-and-hold return. Our buy-and-hold chart shows how CalciMedica, Common performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.CalciMedica, Common Market Price Analysis
Market price analysis indicators help investors to evaluate how CalciMedica, Common stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading CalciMedica, Common shares will generate the highest return on investment. By understating and applying CalciMedica, Common stock market price indicators, traders can identify CalciMedica, Common position entry and exit signals to maximize returns.
CalciMedica, Common Return and Market Media
The median price of CalciMedica, Common for the period between Thu, Sep 19, 2024 and Wed, Dec 18, 2024 is 3.81 with a coefficient of variation of 14.89. The daily time series for the period is distributed with a sample standard deviation of 0.55, arithmetic mean of 3.73, and mean deviation of 0.46. The Stock received substential amount of media coverage during this period. Price Growth (%) |
| Timeline |
1 | Acquisition by Eric Roberts of 45543 shares of CalciMedica, Common at 5.36 subject to Rule 16b-3 | 09/30/2024 |
2 | CalciMedica Announces Upcoming Late-Breaker Plenary Presentation at the American College of Gastroenterology 2024 Annual Scientific Meeting | 10/16/2024 |
3 | Acquisition by Middleton Fred A of 13184 shares of CalciMedica, Common at 3.702 subject to Rule 16b-3 | 10/25/2024 |
4 | Why Carvana Shares Are Trading Higher By Around 20 Here Are 20 Stocks Moving Premarket | 10/31/2024 |
5 | Acquisition by Wilson Robert N of 53333 shares of CalciMedica, Common at 3.75 subject to Rule 16b-3 | 11/01/2024 |
6 | CalciMedica sees significant stock purchase by Sanderling Ventures | 11/05/2024 |
7 | Fred A. Middleton Purchases 87,744 Shares of CalciMedica, Inc. Stock | 11/07/2024 |
8 | CalciMedica GAAP EPS of -0.50 | 11/13/2024 |
9 | CalciMedica to Participate in the Piper Sandler 36th Annual Healthcare Conference | 11/21/2024 |
10 | Acquisition by Middleton Fred A of 4800 shares of CalciMedica, Common at 2.65 subject to Rule 16b-3 | 12/06/2024 |
11 | Insider Activity Roundup Fridays Key Buys and Sells in US Stocks | 12/09/2024 |
About CalciMedica, Common Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including CalciMedica, or other stocks. Alpha measures the amount that position in CalciMedica, Common Stock has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2021 | 2022 | 2023 | 2024 (projected) | PB Ratio | 0.14 | 0.25 | 1.57 | 1.65 | Capex To Depreciation | 0.94 | 6.66 | 1.34 | 1.28 |
CalciMedica, Common Upcoming Company Events
As portrayed in its financial statements, the presentation of CalciMedica, Common's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, CalciMedica, Common's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of CalciMedica, Common's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of CalciMedica, Common. Please utilize our Beneish M Score to check the likelihood of CalciMedica, Common's management manipulating its earnings.
| 8th of February 2024 Upcoming Quarterly Report | View | |
| 10th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 8th of February 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Build Portfolio with CalciMedica, Common
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out CalciMedica, Common Backtesting, CalciMedica, Common Valuation, CalciMedica, Common Correlation, CalciMedica, Common Hype Analysis, CalciMedica, Common Volatility, CalciMedica, Common History and analyze CalciMedica, Common Performance. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.
CalciMedica, Common technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.